The Pharma industry is up 4.1% in the last week, with Novartis up 4.9%. In the past year, the industry is down 11%. Earnings are forecast to grow by 10% annually.
Has the Swiss Pharma Industry valuation changed over the past few years?
Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
---|---|---|---|---|---|---|
Sun, 19 May 2024 | CHF417.8b | CHF113.3b | CHF19.9b | 40.3x | 21x | 3.7x |
Tue, 16 Apr 2024 | CHF402.3b | CHF112.5b | CHF19.5b | 37.3x | 20.7x | 3.6x |
Thu, 14 Mar 2024 | CHF388.3b | CHF110.3b | CHF19.7b | 23.7x | 19.7x | 3.5x |
Sat, 10 Feb 2024 | CHF377.4b | CHF110.0b | CHF19.6b | 24.1x | 19.2x | 3.4x |
Mon, 08 Jan 2024 | CHF412.8b | CHF119.3b | CHF18.6b | 26.8x | 22.2x | 3.5x |
Wed, 06 Dec 2023 | CHF399.9b | CHF120.9b | CHF18.9b | 24.5x | 21.2x | 3.3x |
Fri, 03 Nov 2023 | CHF388.0b | CHF122.8b | CHF19.1b | 23.6x | 20.3x | 3.2x |
Sun, 01 Oct 2023 | CHF407.6b | CHF113.6b | CHF18.2b | 44.4x | 22.4x | 3.6x |
Tue, 29 Aug 2023 | CHF407.1b | CHF111.9b | CHF17.9b | 47.6x | 22.7x | 3.6x |
Thu, 27 Jul 2023 | CHF415.8b | CHF114.1b | CHF19.2b | 36.8x | 21.7x | 3.6x |
Sat, 24 Jun 2023 | CHF425.0b | CHF115.2b | CHF18.9b | 37.2x | 22.5x | 3.7x |
Mon, 22 May 2023 | CHF434.9b | CHF115.3b | CHF18.9b | 39.9x | 23x | 3.8x |
Wed, 19 Apr 2023 | CHF434.1b | CHF114.9b | CHF18.8b | 42.1x | 23.1x | 3.8x |
Fri, 17 Mar 2023 | CHF385.8b | CHF116.5b | CHF19.1b | 25.8x | 20.2x | 3.3x |
Sun, 12 Feb 2023 | CHF407.7b | CHF116.2b | CHF19.0b | 29.1x | 21.4x | 3.5x |
Tue, 10 Jan 2023 | CHF435.4b | CHF116.8b | CHF34.5b | 22.4x | 12.6x | 3.7x |
Thu, 08 Dec 2022 | CHF444.5b | CHF117.9b | CHF35.0b | 22.9x | 12.7x | 3.8x |
Sat, 05 Nov 2022 | CHF456.4b | CHF120.9b | CHF36.2b | 22.8x | 12.6x | 3.8x |
Mon, 03 Oct 2022 | CHF443.3b | CHF120.6b | CHF37.0b | 20.2x | 12x | 3.7x |
Wed, 31 Aug 2022 | CHF444.7b | CHF120.1b | CHF36.8b | 21x | 12.1x | 3.7x |
Fri, 29 Jul 2022 | CHF461.1b | CHF119.7b | CHF36.6b | 28x | 12.6x | 3.9x |
Sun, 26 Jun 2022 | CHF446.7b | CHF118.3b | CHF37.2b | 26.8x | 12x | 3.8x |
Tue, 24 May 2022 | CHF466.5b | CHF118.9b | CHF37.5b | 28.6x | 12.5x | 3.9x |
Thu, 21 Apr 2022 | CHF507.8b | CHF117.8b | CHF36.8b | 32.5x | 13.8x | 4.3x |
Sat, 19 Mar 2022 | CHF489.0b | CHF117.1b | CHF36.4b | 21.1x | 13.4x | 4.2x |
Mon, 14 Feb 2022 | CHF453.9b | CHF116.6b | CHF36.3b | 18.7x | 12.5x | 3.9x |
Wed, 12 Jan 2022 | CHF501.0b | CHF112.3b | CHF23.2b | 21.5x | 21.6x | 4.5x |
Fri, 10 Dec 2021 | CHF480.8b | CHF112.4b | CHF23.3b | 21.4x | 20.7x | 4.3x |
Sun, 07 Nov 2021 | CHF497.8b | CHF111.7b | CHF23.1b | 22.2x | 21.5x | 4.5x |
Tue, 05 Oct 2021 | CHF484.9b | CHF111.6b | CHF22.5b | 21.3x | 21.6x | 4.3x |
Thu, 02 Sep 2021 | CHF518.4b | CHF111.6b | CHF22.5b | 22.8x | 23x | 4.6x |
Sat, 31 Jul 2021 | CHF519.6b | CHF111.6b | CHF22.5b | 24.6x | 23.1x | 4.7x |
21x
How does Swiss Pharma compare with similar industries?
CH Market | 1.97% | |
Healthcare | 3.33% | |
Pharma | 3.07% | |
Pharma | 3.07% |
Which companies have driven the market over the last 7 days?
Company | Last Price | 7D | 1Y | Valuation | |
---|---|---|---|---|---|
ROG Roche Holding | CHF237.10 | 5.3% +CHF9.6b | -17.7% | PE16.4x | |
NOVN Novartis | CHF93.37 | 1.1% +CHF2.1b | 3.2% | PE23x | |
GALD Galderma Group | CHF73.88 | 5.3% +CHF887.4m | n/a | n/a | |
COPN Cosmo Pharmaceuticals | CHF72.90 | 3.0% +CHF33.7m | 42.1% | PE1033.2x | |
NWRN Newron Pharmaceuticals | CHF10.60 | 8.4% +CHF15.3m | 137.7% | PS22.1x |